GHG Emissions, Industrial, Sourcing Renewables - June 13, 2023
AstraZeneca to Add RNG at All Production Sites
AstraZeneca is entering into a partnership to deliver renewable natural gas (RNG) to all of its sites in the U.S. by the end of 2026.
Beginning June 2023, AstraZeneca purchased RNG produced by Vanguard Renewables for its Newark Campus in Delaware where the company packages 26 medicines for distribution across the U.S. and makes medicine formulations for global supply.
By 2026, as much as 650,000 million British thermal units (MMBtu) or 190,500-megawatt hours (MWh) per year of RNG are expected to be used across AstraZeneca’s U.S. sites.
This agreement will use Vanguard Renewables Farm Powered® process, allowing Vanguard to work with dairy farmers and food and beverage manufacturers, retailers and distributors to produce RNG using farm-based anaerobic digestion (AD) from food and dairy cow manure. Once the RNG is produced and captured through AD, it will be injected into the existing natural gas infrastructure for use in AstraZeneca medicines research and manufacturing processes.
“We recognize the interconnection between the health of people and the planet, and are committed to driving deep decarbonization across our operations and value chain, said Pam Cheng, Executive Vice President of Global Operations & IT and Chief Sustainability Officer at AstraZeneca, in a statement. “Our innovative partnership with Vanguard Renewables in the U.S. is an illustration of how we are collaborating at scale to deliver sustainable science and medicines, as part of the transition to net zero health systems and a circular economy.”
AstroZeneca views this partnership as an important milestone in delivering emissions reductions of lowering GHG emissions from its global operations (Scope 1 and 2) by 98% by 2026 from a 2015 baseline. By 2030, the company aims to halve its entire value chain footprint on the way to becoming science-based net zero by 2045.
Read These Related Articles:
Stay Up-To-Date
